6 / 220
Medium Used
The Home Study Course is available in electronic or print format. The activity includes a review of
outcomes objectives, selected scientific literature, and a self-assessment examination.
Method of Physician Participation in the Learning Process
The physician learner will read the selected scientific literature, reflect on what they have read,
and complete the self-assessment exam. After completing this section, participants should have a
greater understanding of Neoplastic and Inflammatory Diseases of the Head and Neck as they
affect the head and neck area, as well as useful information for clinical application.
Estimated time to complete this activity:
40.0 hours
Accreditation Statement
The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) is
accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical
education for physicians.
Credit Designation
The AAO-HNSF designates this enduring material for 40.0
AMA PRA Category 1 Credit(s)
™. Physicians
should claim credit commensurate with the extent of their participation in the activity.
ALL PARTICIPANTS must
achieve a post-test score of 70% or higher for a passing completion to be
recorded and a transcript to be produced. Residents; results will be provided to the Training Program
Director.
PHYSICIANS ONLY
: In order to receive
Credit
for this activity
a post-test score of 70% or higher is
required
. Two retest opportunity will be automatically be available if a minimum of 70% is not
achieved.
Disclosure
The American Academy of Otolaryngology Head and Neck Surgery/Foundation (AAO-HNS/F) supports fair and
unbiased participation of our volunteers in Academy/Foundation activities. All individuals who may be in a
position to control an activity’s content must disclose all relevant financial relationships or disclose that no relevant
financial relationships exist. All relevant financial relationships with commercial interests
1
that directly impact
and/or might conflict with Academy/Foundation activities must be disclosed. Any real or potential conflicts of
interest
2
must be identified, managed, and disclosed to the learners. In addition, disclosure must be made of
presentations on drugs or devices, or uses of drugs or devices that have not been approved by the Food and Drug
Administration. This policy is intended to openly identify any potential conflict so that participants in an activity
are able to form their own judgments about the presentation.
[1]
A “Commercial interest” is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
2
“Conflict of interest” is defined as any real or potential situation that has competing professional or personal interests that would make it difficult to be
unbiased. Conflicts of interest occur when an individual has an opportunity to affect education content about products or services of a commercial interest with
which they have a financial relationship.
A conflict of interest depends on the situation and not on the character of the individual.